 |
FDA Approval Activities for this Drug
Patanol (olopatadine hydrochloride ophthalmic solution), 0.1%, Alcon, NDA 20-688/S-016 4/17/03
| Patanol (olopatadine ophthalmic solution), 0.1%, Alcon NDA 20-688/S12 3/20/00 3/21/00
| Patanol Indications: Treatment of signs and symptoms of allergic conjunctivitis. | Olopatadine hydrochloride ophthalmic solution, Alcon, Inc., Approval | Olopatadine Hydrochloride Ophthalmic Solution, Alcon Research, Labeling Revision | Pataday (olopatadine hydrochloride) Ophthalmic Solution, Alcon Research, Labeling Revision | Pataday (olopatadine hydrochloride) Ophthalmic Solution, Alcon Research, Labeling Revision & Package Change | Olopatadine Hydrochloride Ophthalmic Solution, Apotex, Tentative Approval | Patanase (olopatadine hydrochloride) Nasal Spray, Alcon Research, Approval | Patanase Nasal Spray (olopatadine hydrochloride), Alcon Pharmaceuticals, Inc., Efficacy Supp w/Clinical Data | Patanase (olopatadine hydrochloride) Nasal Spray, Alcon Research, Ltd., Efficacy Supp. w/Clinical Data | Olopatadine Hydrochloride Ophthalmic Solution, Sandoz Inc., Tentative Approval | Patanase (olopatadine hydrochloride) Nasal Spray, Alcon Research, Ltd., Efficacy Supplement with Clinical Data to Support | Pataday (olopatadine hydrochloride) Ophthalmic Solution, Alcon, Inc., Labeling Revision | Olopatadine Hydrochloride Ophthalmic Solution, Barr Laboratories, Inc., Tentative Approval | Olopatadine Hydrochloride Ophthalmic Solution, Wockhardt, Ltd., Tentative Approval | Olopatadine hydrochloride Ophthalmic Drops, Apotex, Inc., Tentative Approval | Olopatadine Hydrochloride Ophthalmic Solution, Apotex Corp., Tentative Approval
^ FDA's latest approval appears at the bottom of this list. ^
|